Align Technology reported $1.02B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
3M USD 6.58B 84M Sep/2026
Align Technology USD 1.02B 40M Sep/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Cardinal Health USD 67.51B 3.81B Sep/2026
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
CVS Health USD 108.4B 2.3B Sep/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 836M 62M Sep/2026
Dexcom USD 1.34B 30M Sep/2026
Henry Schein USD 3.47B 10M Sep/2026
Idexx Laboratories USD 1.21B 10M Sep/2026
Insulet USD 842M 40.3M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
McKesson USD 110.96B 5.58B Sep/2026
Mettler Toledo International USD 1.09B 60M Sep/2026
Revvity USD 729M 680K Sep/2026
Solventum Corp USD 1.95B 250M Sep/2026
Stryker USD 6.5B 100M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Veeva Systems USD 927.96M 45.02M Jun/2026
Waters USD 1.77B 130M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026
Zoetis USD 2.4B 100M Sep/2026